["{\n\"step_by_step_thinking\": \"The provided documents discuss the use of thromboprophylaxis with low molecular weight heparin (LMWH) for postoperative prevention of deep vein thrombosis. The studies suggest that LMWH can be administered subcutaneously, which is a common method of prophylactic pharmacological agent administration among surgeons who use thromboprophylaxis. Additionally, the document on interaction of heparinoids with platelets mentions that low molecular weight heparins are often used for thromboprophylaxis and have little or no inhibitory activity in platelet-collagen interactions. This implies that subcutaneous administration is a suitable route for LMWH.\",\n\"answer_choice\": \"A\""]